COVID-19: First copies of Gilead virus drug to start selling in Bangladesh | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Thursday
July 10, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
THURSDAY, JULY 10, 2025
First copies of Gilead virus drug to start selling in Bangladesh

Coronavirus chronicle

Arun Devnath
21 May, 2020, 12:20 pm
Last modified: 21 May, 2020, 12:43 pm

Related News

  • 2 cleaners killed in covered van crash in Dhaka
  • One dies from COVID-19 in 24 hrs
  • Ulan Daspara: Remnants of a fishing village in Dhaka
  • Online GD service to be launched in Dhaka, Mymensingh tomorrow
  • Covid-19: Two more deaths, 7 new cases reported in 24hrs

First copies of Gilead virus drug to start selling in Bangladesh

The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals treating Covid-19 patients

Arun Devnath
21 May, 2020, 12:20 pm
Last modified: 21 May, 2020, 12:43 pm
A vial of Remdesivir. Photographer: Ulrich Perrey/Getty Images
A vial of Remdesivir. Photographer: Ulrich Perrey/Getty Images

Bangladesh's Beximco Pharmaceuticals Ltd. said it has become the world's first company to start selling the generic version of Gilead Sciences Inc.'s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world.

The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals treating Covid-19 patients, Rabbur Reza, chief operating officer at the company, said in an interview. A critically ill Covid-19 patient will need at least six vials, he said.

Bangladesh can produce generic versions of patented drugs under World Trade Organization provisions that grant least developed countries a waiver from seeking licenses. Remdesivir was cleared by U.S. drug regulator for emergency use in Covid-19 patients, becoming the first medication backed by early clinical data to be made available to fight the novel pathogen.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

'Receiving Queries'

"We're also receiving queries from other countries," Reza said. "The drug will not be supplied through traditional distribution channels. If some governments need our drug, we'll export it."

Bangladesh had more than 26,000 infected cases as of Wednesday, while the disease had killed 386, according to data from Johns Hopkins University

The United Nations-backed Medicines Patent Pool, which is helping Gilead find partners, contacted Beximco asking if it was interested in the voluntary licensing for remdesivir, said Reza. Beximco is waiting to hear back, he said.

A Gilead representative didn't respond to an email seeking comment.

Gilead Gives Royalty-Free Remdesivir Licenses to Five Drugmakers

Gilead has since licensed five companies including Cipla Ltd. and Mylan NV in India and Ferozsons Laboratories Ltd. in Pakistan to make generic versions of the drug and sell in 127 countries.

Norway's Norges Bank, the world's biggest sovereign fund, controls 3% of Beximco, according to data compiled by Bloomberg. Beximco will sell the drug under the brand name bemsivir, according to a statement from the company.


Disclaimer: This article first appeared on Bloomberg.com, and is published by special syndication arrangement."

Top News

COVID-19 / Dhaka / Beximco Pharmaceuticals Ltd / remdesivir

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • In terms of stream of education, girls maintained their excellence as well. Photo: TBS
    Lowest SSC pass rate in 17 years as over 6 lakh students fail
  • BNP Secretary General Mirza Fakhrul Islam Alamgir while speaking at a discussion at National Press Club on 10 July 2025. Photo: TBS
    'Backbone of economy will break': Fakhrul says govt should've worked seriously with more qualified people on US tariffs
  • S Alam Group Chairman Mohammed Saiful Alam. Photo: Collected
    Court freezes foreign investments of S Alam Group chairman, family in Singapore

MOST VIEWED

  • Graphics: TBS
    BB raises startup fund limit, drops upper age barrier
  • Workers pack undergarments at the packing section of a garment factory in Ashulia, on the outskirts of Dhaka, Bangladesh, April 19, 2025. Photo: REUTERS/Fatima Tuj Johora
    After US tariffs, jobs hang by a thread in Bangladesh's garments sector
  • Global Islami Bank rectifies 2023 figures, reports Tk2,259cr loss instead of Tk128cr profit
    Global Islami Bank rectifies 2023 figures, reports Tk2,259cr loss instead of Tk128cr profit
  • Bangladesh Bank Governor Ahsan H Mansur. TBS Sketch
    Audit reports of most banks contain cooked up data: BB governor
  • File photo of containers at Chattogram port/TBS
    US buyers push Bangladeshi exporters to share extra tariff costs
  • CA orders law enforcers to complete all election preparations by December
    CA orders law enforcers to complete all election preparations by December

Related News

  • 2 cleaners killed in covered van crash in Dhaka
  • One dies from COVID-19 in 24 hrs
  • Ulan Daspara: Remnants of a fishing village in Dhaka
  • Online GD service to be launched in Dhaka, Mymensingh tomorrow
  • Covid-19: Two more deaths, 7 new cases reported in 24hrs

Features

Illustration: TBS

Behind closed doors: Why women in Bangladesh stay in abusive marriages

1h | Panorama
Purbachl’s 144-acre Sal forest is an essential part of the area’s biodiversity. Within it, 128 species of plants and 74 species of animals — many of them endangered- have been identified. Photo: Syed Zakir Hossain/TBS

A forest saved: Inside the restoration of Purbachal's last Sal grove

2h | Panorama
Women are forced to fish in saline waters every day, risking their health to provide for their families. Photo: TBS

How Mongla’s women are bearing the brunt of rising salinity

23h | Panorama
Dr Mostafa Abid Khan. Sketch: TBS

Actual impact will depend on how US retailers respond: Mostafa Abid Khan

2d | Economy

More Videos from TBS

SSC and equivalent results released: Pass rate 68.45%, GPA drops by 5

SSC and equivalent results released: Pass rate 68.45%, GPA drops by 5

25m | TBS Today
Islami bank aims to increase deposits to Tk 2 lakh crore by 2025

Islami bank aims to increase deposits to Tk 2 lakh crore by 2025

2h | TBS Programs
The two countries still face major challenges and mutual suspicions

The two countries still face major challenges and mutual suspicions

1h | Others
RMG sector braces for impact as US tariffs hit: Fakhrul

RMG sector braces for impact as US tariffs hit: Fakhrul

3h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net